Annalen der klinischen und Laborforschung

  • ISSN: 2386-5180
  • H-Index der Zeitschrift: 17
  • Zitierbewertung der Zeitschrift: 6.26
  • Journal-Impact-Faktor: 5.31
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • Publons
  • Euro-Pub
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
Teile diese Seite

Abstrakt

The impact of drug metabolism on drug design and optimization of prodrugs to metabolite targeting

Rosie Janina

Drug metabolism plays a significant role in drug design and optimization, shaping the pharmacokinetic and pharmacodynamics properties of pharmaceutical compounds. Understanding the metabolic fate of drugs in the body is crucial for enhancing their efficacy, improving safety profiles and maximizing therapeutic outcomes. This article explores the profound impact of drug metabolism on drug design and optimization, highlighting the utilization of prodrugs and metabolite targeting strategies to enhance drug performance